IGF2BP1, a member of the IGF2BPs family, was then identified as an oncogene that promotes cancer development by antagonizing cancer-suppressive miRNAs (Müller et al., 2018; Müller et al., 2019). The gene discussed is IGF2BP1; the disease is cancer.